Post-IPO Equity Companies in Cambridge

Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.

Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.

Prime Medicine is a biotechnology company that utilizes Prime Editing to modify genetic sequences to treat a wide range of diseases.

Oxys is an IIoT company that provides services and products for the industrial of the internet of things.

Cue Biopharma is a developer of a productive platform for the treatment of cancer and autoimmune disease.

Elicio Therapeutics is a pharmaceutical research company that develops an immuno-tumor vaccine to treat cancer.

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.

Evelo Biosciences is a biotechnology company that develops oral biologics for small intestinal axis with systemic therapeutic effects.

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

Blueprint Medicines develops precision therapies for genomically defined cancers and rare diseases.

Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

Decoy Therapeutics is a biotech company that design the next generation of peptide conjugate therapies to protect and expand patient lives.

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.

Cyclerion Therapeutics harnesses the potential of soluble guanylate cyclase (sGC) pharmacology.

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.

ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.

Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.